137 related articles for article (PubMed ID: 8538619)
21. Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours.
Suchy B; Waldmann V; Klugbauer S; Rabes HM
Br J Cancer; 1998 Mar; 77(6):952-5. PubMed ID: 9528840
[TBL] [Abstract][Full Text] [Related]
22. Thyroid stimulating hormone (TSH)-associated follicular hypertrophy and hyperplasia as a mechanism of thyroid carcinogenesis in mice and rats.
Thomas GA; Williams ED
IARC Sci Publ; 1999; (147):45-59. PubMed ID: 10457909
[No Abstract] [Full Text] [Related]
23. Oncogenes and thyroid cancer.
Vecchio G; Santoro M
Clin Chem Lab Med; 2000 Feb; 38(2):113-6. PubMed ID: 10834397
[TBL] [Abstract][Full Text] [Related]
24. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
[TBL] [Abstract][Full Text] [Related]
25. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France.
Pacini F; Vorontsova T; Demidchik EP; Molinaro E; Agate L; Romei C; Shavrova E; Cherstvoy ED; Ivashkevitch Y; Kuchinskaya E; Schlumberger M; Ronga G; Filesi M; Pinchera A
J Clin Endocrinol Metab; 1997 Nov; 82(11):3563-9. PubMed ID: 9360507
[TBL] [Abstract][Full Text] [Related]
26. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
Gagel RF
Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
[TBL] [Abstract][Full Text] [Related]
27. In vitro reconstruction of tumour initiation in a human epithelium.
Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D
Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590
[TBL] [Abstract][Full Text] [Related]
28. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
[TBL] [Abstract][Full Text] [Related]
30. Oncogenes and growth factors in thyroid carcinogenesis.
Frauman AG; Moses AC
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
[TBL] [Abstract][Full Text] [Related]
31. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
[TBL] [Abstract][Full Text] [Related]
32. Growth regulation of thyroid and thyroid tumors in humans.
Goretzki PE; Simon D; Dotzenrath C; Schulte KM; Röher HD
World J Surg; 2000 Aug; 24(8):913-22. PubMed ID: 10865035
[TBL] [Abstract][Full Text] [Related]
33. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
[TBL] [Abstract][Full Text] [Related]
34. Carcinogenic effect of 100, 250 and 500 rad X-rays on the rat thyroid gland.
Doniach I
Br J Cancer; 1974 Dec; 30(6):487-95. PubMed ID: 4447781
[TBL] [Abstract][Full Text] [Related]
35. [Genetic factors predisposing to the development of papillary thyroid cancer].
Puzianowska-Kuźnicka M; Pietrzak M
Endokrynol Pol; 2005; 56(3):339-45. PubMed ID: 16350729
[TBL] [Abstract][Full Text] [Related]
36. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus.
Nikiforov Y; Gnepp DR
Cancer; 1994 Jul; 74(2):748-66. PubMed ID: 8033057
[TBL] [Abstract][Full Text] [Related]
37. Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene.
Bartolone L; Vermiglio F; Finocchiaro MD; Violi MA; French D; Pontecorvi A; Trimarchi F; Benvenga S
J Endocrinol Invest; 1998 Nov; 21(10):680-7. PubMed ID: 9854684
[TBL] [Abstract][Full Text] [Related]
38. New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
Riesco-Eizaguirre G; Santisteban P
Endocr Relat Cancer; 2007 Dec; 14(4):957-77. PubMed ID: 18045949
[TBL] [Abstract][Full Text] [Related]
39. Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.
Tanaka K; Inoue H; Miki H; Masuda E; Kitaichi M; Komaki K; Uyama T; Monden Y
Br J Cancer; 1997; 76(5):594-9. PubMed ID: 9303357
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
